Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-02 18:00 |
Amoéba's Board of Directors renewed to support the company's new strategic ambi…
|
English | 371.9 KB | ||
| 2024-04-29 17:45 |
AMOEBA ANNONCE LA MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023
|
French | 287.9 KB | ||
| 2024-04-29 17:45 |
AMOEBA ANNOUNCES AVAILABILITY OF UNIVERSAL REGISTRATION DOCUMENT 2023
|
English | 281.6 KB | ||
| 2024-04-29 08:55 |
AMOEBA : DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023
|
French | 5.1 MB | ||
| 2024-04-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | 240.4 KB | ||
| 2024-03-28 18:30 |
Amoéba: 2023 full-year earnings - A year of transition in preparation for the l…
|
English | 662.7 KB | ||
| 2024-03-28 18:30 |
Amoéba : Résultats 2023 – Une année de transition en vue de la commercialisatio…
|
French | 693.4 KB | ||
| 2024-03-12 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | 227.6 KB | ||
| 2024-02-15 08:45 |
AMOEBA : Informations complémentaires et axes de croissance
|
French | 245.2 KB | ||
| 2024-02-15 08:45 |
AMOEBA: Additional information and areas for growth
|
English | 242.9 KB | ||
| 2024-02-09 08:55 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | 259.3 KB | ||
| 2024-02-05 08:45 |
AMOEBA: Corporate governance change and review of the company's growth strategy
|
English | 343.5 KB | ||
| 2024-02-05 08:45 |
AMOEBA : Rappel du changement de Gouvernance et révision des axes de croissance…
|
French | 340.3 KB | ||
| 2024-01-18 08:00 |
AMOEBA : Calendrier de communication financière 2024
|
French | 323.7 KB | ||
| 2024-01-17 15:40 |
Franchissements de seuils et déclaration d'intention
|
French | 276.4 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
